Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.
about
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Application of quality by design to the process development of botanical drug products: a case study.Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.Scientific, statistical, practical, and regulatory considerations in design space development.Developing a quality by design approach to model tablet dissolution testing: an industrial case study.Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study.
P2860
Q34610568-181065E0-4A53-4FFA-81D7-D6175CAF0890Q36636575-B7E0E27E-6FF6-4E2A-8FB0-454880B429A7Q42046999-1DC43BDD-DF5E-41B4-8232-7DF58F322473Q42056839-DF3EE4A5-E429-4371-BECE-5F25B8BEC678Q45259769-E3AEF1C2-6667-470B-92A8-79913B216221Q46465572-59DBE47A-0C63-4C7C-BAA9-307C50BD504AQ46506603-F5706FB2-F797-4C80-BF3C-69E0CAE5D793Q46647863-A9CBE276-6823-479C-9AE9-B3B8D67D5D08Q47376114-94CD28C9-C1E8-40DF-9BDD-A234E08D8FFEQ47390440-1B6AFFF8-11ED-4957-B776-79E1157CD398Q54422355-C2A098B7-A4FB-4D06-9DD4-CFFC06BB3D89
P2860
Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Application of pharmaceutical ...... of controlled-release tablets.
@en
type
label
Application of pharmaceutical ...... of controlled-release tablets.
@en
prefLabel
Application of pharmaceutical ...... of controlled-release tablets.
@en
P2860
P1433
P1476
Application of pharmaceutical ...... of controlled-release tablets
@en
P2093
Emad B Basalious
Wessam El-Sebaie
P2860
P2888
P304
P356
10.1208/S12249-011-9646-6
P407
P577
2011-06-24T00:00:00Z
P5875
P6179
1050613059